Intended for healthcare professionals

Letters Drug company influence

COPD: inhalers distract from exercise and clean air

BMJ 2019; 365 doi: (Published 17 May 2019) Cite this as: BMJ 2019;365:l2156
  1. Nicholas Sharvill, general practitioner
  1. Deal, UK
  1. john.sharvill{at}

Salisbury says that Boehringer Ingelheim is paying £748 000 (€868 000; $973 000) towards an integrated multidisciplinary respiratory team in Oxford, compared with £181 000 from the clinical commissioning group (CCG).1 I hope the CCG finance and …

View Full Text

Log in

Log in through your institution


* For online subscription